BTMD Stock Price, Chart, Stats & News

biote Corp.
Save
107.18M
Market cap
5.52x
Current P/E
6.14x
Forward P/E
BTMD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 71.46% |
Operating margin | 18.50% |
Pretax margin | 19.55% |
Net margin | 14.07% |
Effective tax rate | 15.93% |
ROA | 25.13% |
ROE | -35.31% |
D/E | -1.88x |
Interest coverage ratio | 3.24x |
BTMD valuation
P/E | 5.52x |
P/S | 0.30x |
P/B | -0.69x |
P/CF | 1.15x |
P/FCF | 1.94x |
P/OCF | 1.15x |
PEG | -0.23x |
EV multiple | -0.70x |
About
Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements.
Similar securities
Based on sector and market capitalization
Report issue











